You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 108 No. 1, July 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Therapy of Hypoplastic Anemia with Bone Marrow Transplantation

CDR WILLIAM McFARLAND, MC; NORMA GRANVILLE, M.D.; ROBERT SCHWARTZ, M.D.; HERMAN OLINER, M.D.; D. K. MISRA, M.D.; WILLIAM DAMESHEK, M.D.

Arch Intern Med. 1961;108(1):23-33.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The therapy of hypoplastic anemia may be said to be far from satisfactory. In addition to blood transfusions, numerous measures have been tried, including corticotropin (ACTH) and the corticosteroids,1 cobalt,2 testosterone,3 and splenectomy.4 In some cases, one or another of these measures proves to be beneficial, but in most, few if any lasting effects are noted. During the past 3 years our laboratory has been investigating the use of bone marrow transplantation as a therapeutic measure in this disease. The purpose of this paper is to report the results of this study.

Materials and Methods

Patient Material.—

Thirty-seven cases of hypoplastic anemia were observed. All patients under study had a disorder characterized by: (1) severe pancytopenia, (2) hypoplasia of the bone marrow with at least 50% replacement of the normal marrow hematopoietic cells by fat, (3) the absence of splenomegaly, and (4) the absence of other . . . [Full Text PDF of this Article]


Author Affiliations

USN; BOSTON

From the Blood Research Laboratory, Pratt Diagnostic Clinic-New England Center Hospital and the Department of Medicine, Tufts University School of Medicine.; Formerly a Research Fellow in Hematology, Blood Research Laboratory, New England Center Hospital, presently at U.S. Naval Hospital, Bethesda, Md. (CDR McFarland); formerly a Research Fellow in Hematology, Blood Research Laboratory, New England Center Hospital, presently at St. Francis Hospital, Hartford, Conn. (Dr. Granville); Research Associate in Hematology, Blood Research Laboratory, New England Center Hospital, under tenure of a U.S. Public Health Service Fellowship No. HF-7166(C) (Dr. Schwartz); Research Fellow in Hematology, Blood Research Laboratory, New England Center Hospital, under tenure of a U.S. Public Health Service Fellowship No. CF-9754 (Dr. Oliner); Senior Research Fellow in Hematology, Blood Research Laboratory, New England Center Hospital (Dr. Misra); Director, Blood Research Laboratory, New England Center Hospital, Professor of Medicine, Tufts University School of Medicine (Dr. Dameshek).


Footnotes

Submitted for publication Aug. 4, 1960.

Aided by a grant from the U.S. Atomic Energy Commission, Contract AT (20-1)2032.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.